15/02/19 Spring Pharmaceutical Group, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018 CI
13/11/18 Spring Pharmaceutical Group, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2018 CI
31/08/18 China YCT International Group, Inc. has Changed its Name to Spring Pharmaceutical Group, Inc CI
14/08/18 China YCT International Group, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2018 CI
15/11/17 China YCT International Group, Inc Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2017 CI
12/07/17 China YCT International Group, Inc Announces Financial Results for the Year Ending March 31, 2017 CI
24/04/17 China YCT International Group, Inc Appoints Li Dong to the Board of Directors CI
28/03/17 Shandong Yongchuntang Group Co., Ltd acquired 3% stake in Shandong Spring Pharmaceutical Co., Ltd. from China YCT International Group, Inc. CI
16/07/15 China YCT International Group Inc. Reports Earnings Results for the Fiscal Year Ended March 31, 2015 CI
15/08/14 CYIG Signs Strategic Cooperation Agreement with Xi'an Putian Pharmacy CI
22/07/14 China YCT International Group, Inc Reports Earnings Results for the Year Ended March 31, 2014 CI
29/10/12 L.Y.(HK) Biotech Limited cancelled the acquisition of China YCT International Group, Inc in a reverse merger transaction. CI
Manager TitleAgeSince
Chief Executive Officer 71 01/01/2007
Director of Finance/CFO 61 04/03/2011
Chief Administrative Officer 54 -
Director TitleAgeSince
Chairman 71 01/01/2007
Director/Board Member 70 13/10/2010
Director/Board Member 75 06/04/2009
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+1.56% - - 1.14M
+3.60%+0.88%+75.59%+124.32% 1,093B
+3.33%+4.35%+53.82%+57.17% 653B
+3.43%+3.53%+25.34%+72.45% 458B
+0.33%-0.85%+39.28%+42.51% 355B
-0.02%+1.16%+24.52%+39.60% 294B
+0.46%+1.37%+0.68%+11.13% 248B
+1.41%+2.65%+45.34%+62.43% 230B
-1.16%-2.12%-15.77%-53.51% 203B
+3.25%+5.65%+21.57%+89.04% 178B
Average +1.46%+1.20%+30.04%+49.46% 412.27B
Weighted average by Cap. +2.31%+1.45%+43.58%+68.76%
Logo Spring Pharmaceutical Group, Inc.
SPRING PHARMACEUTICAL GROUP, INC., formerly China YCT International Group, Inc., operates through two of its subsidiaries, Landway Nano Bio-Tech Group, Inc. (Landway Nano) and Shandong Spring Pharmaceutical Co., Ltd. (Shandong Spring Pharmaceutical). Through its subsidiaries, the Company is engaged in the distribution of health care supplement products, and in the development, manufacture and sales of Huoliyuan capsules, and in the development of the acer truncatum bunge planting bases and selling acer truncatum seed oil.
Employees
-